RxDoctor Payments Data

Brent Ogle, DO

Family Medicine · Mount Vernon, OHNPI 1689606451

Payments from drug & device makers

$10,054in general payments, 2019–2025

Across 736 payments — averaging $13.66 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$1K
  • Novo Nordisk$1K
  • Pfizer$1K
  • AstraZeneca$895
  • GSK$667
  • Amgen$471
  • plus $4K from 38 others

What the payments were for

  • Food & beverage$10,044100%
  • Education$100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$10,054 in reported general payments places this provider in the 90th percentile of 3,983 family medicine providers in Ohio.

See all family medicine providers in Ohio

Medicare billing

Part B allowed, 2024
$163,725
Medicare patients
242
Services billed
4,052

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban99$117,889
OzempicSemaglutide44$58,583
JardianceEmpagliflozin45$43,248
Breztri AerosphereBudesonide/Glycopyr/Formoterol44$27,206
FarxigaDapagliflozin Propanediol31$26,110
JanuviaSitagliptin Phosphate18$20,113
JanumetSitagliptin Phos/Metformin Hcl12$18,940
XareltoRivaroxaban15$18,205
Trelegy ElliptaFluticasone/Umeclidin/Vilanter11$10,873
Atorvastatin Calcium410$4,168
NexiumEsomeprazole Magnesium11$3,519
Fluticasone-SalmeterolFluticasone Propion/Salmeterol31$3,290
Albuterol Sulfate HfaAlbuterol Sulfate112$2,784
Duloxetine Hcl73$2,457
Gabapentin173$2,367

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
PfizerEliquis$1,052$117,88999 claims
Novo NordiskOzempic$1,230$58,58344 claims
AstraZenecaBreztri Aerosphere, Farxiga, Nexium$895$56,83586 claims
Boehringer IngelheimJardiance$182$43,24845 claims
MerckJanuvia, Janumet$339$39,05330 claims
Johnson & JohnsonXarelto$413$18,20515 claims
GSKTrelegy Ellipta$667$10,87311 claims
AbbVieSynthroid$1,288$91428 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 3,983 family medicine providers in Ohio.

Other family medicine in Mount Vernon

See the full list for Ohio

Where these figures come from

Is this you, or does something look wrong? →